Investor's Business Daily on MSN
Stocks to watch: Vor Biopharma sees RS rating jump to 89
On Wednesday, Vor Biopharma VOR hit a noteworthy technical benchmark, seeing its Relative Strength (RS) Rating jump into the ...
Discover Vor BiopharmaVor Biopharma Inc.'s potential with telitacicept amid funding challenges and market risks. Click for ...
Vor Biopharma ( ($VOR) ) has provided an update. On December 15, 2025, Vor Bio entered into a securities purchase agreement for a $150 million ...
Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...
Vor Biopharma Inc. (VOR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
Seeing the surge in the popularity of crypto investments, IRAEmpire has published a new guide on how to start a crypto IRA to help investors make better informed decisions. PORTLAND, OREGON / ACCESS N ...
US stocks opened mixed today. The Dow hit 47,939.87. The S&P 500 inched to 6,853.95. The Nasdaq slipped to 23,498.96. Markets ...
Japan's largest multiple system operator deploys its first AI-enabled Wi-Fi 7 service to support the growing needs of its ...
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback